Form 4: MEDIFAST CEO Daniel Chard Acquires Additional Shares Through Family Trust

MEDIFAST, Inc. Chairman and CEO Daniel R. Chard reported the acquisition of 381 shares of common stock at $13.13 per share through an irrevocable family trust, increasing his indirect beneficial ownership.

Summary

• Daniel R. Chard, Chairman & CEO and a Director of MEDIFAST, Inc. (MED), acquired 381 shares of common stock.
• The transaction occurred on June 13, 2025, at a price of $13.13 per share.
• The shares were acquired indirectly through The Dan and Allyson Family Irrevocable Trust.
• Following this transaction, Mr. Chard's indirect beneficial ownership through the trust is 149,698.352 shares.
• His direct beneficial ownership remains at 176,246 shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase.

Sentiment

Score: 7

Explanation: The acquisition of shares by the Chairman & CEO is generally viewed as a positive signal of confidence in the company's future prospects, although the transaction volume is relatively small.

Positives

• The acquisition of additional shares by the Chairman & CEO signals confidence in the company's future prospects and valuation.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-planned investment strategy.

Related Party Transactions

• The acquisition of shares was made indirectly through The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee, constituting a related party transaction.

Stakeholder Impact

• Shareholders may interpret the CEO's purchase as a positive sign of management's belief in the company's value and future performance.

Key Dates

Recommendation

Keywords

MEDIFAST, MED, Daniel Chard, insider purchase, Form 4, beneficial ownership, CEO, director, stock acquisition, Rule 10b5-1